Global Newcastle Disease Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 356 million in 2025 and is forecast to a readjusted size of US$ 443 million by 2032 with a CAGR of 3.2% during review period.
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
This report is a detailed and comprehensive analysis for global Newcastle Disease Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newcastle Disease Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Newcastle Disease Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
This report is a detailed and comprehensive analysis for global Newcastle Disease Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newcastle Disease Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Newcastle Disease Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Newcastle Disease Vaccine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Newcastle Disease Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Live Vaccines
- Killed Vaccines
- Spray Method
- Drinking Water
- Injection Method
- Large Farms
- Small Farms
- Government Use
- Chicken
- Duck & Goose
- Other
- Boehringer Ingelheim
- CEVA
- CAHIC
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- Elanco
- FATRO
- CAVAC
- Vaksindo
- Virbac
- Hester Biosciences
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales quantity, revenue, and global market share of Newcastle Disease Vaccine from 2021 to 2026.
- Chapter 3, the Newcastle Disease Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Newcastle Disease Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Newcastle Disease Vaccine.
- Chapter 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live Vaccines
1.3.3 Killed Vaccines
1.4 Market Analysis by Administration
1.4.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Administration: 2021 Versus 2025 Versus 2032
1.4.2 Spray Method
1.4.3 Drinking Water
1.4.4 Injection Method
1.5 Market Analysis by End User
1.5.1 Overview: Global Newcastle Disease Vaccine Consumption Value by End User: 2021 Versus 2025 Versus 2032
1.5.2 Large Farms
1.5.3 Small Farms
1.5.4 Government Use
1.6 Market Analysis by Application
1.6.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Chicken
1.6.3 Duck & Goose
1.6.4 Other
1.7 Global Newcastle Disease Vaccine Market Size & Forecast
1.7.1 Global Newcastle Disease Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Newcastle Disease Vaccine Sales Quantity (2021-2032)
1.7.3 Global Newcastle Disease Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
2.1.4 Boehringer Ingelheim Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 CEVA
2.2.1 CEVA Details
2.2.2 CEVA Major Business
2.2.3 CEVA Newcastle Disease Vaccine Product and Services
2.2.4 CEVA Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CEVA Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Newcastle Disease Vaccine Product and Services
2.3.4 CAHIC Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CAHIC Recent Developments/Updates
2.4 Ringpu Biology
2.4.1 Ringpu Biology Details
2.4.2 Ringpu Biology Major Business
2.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
2.4.4 Ringpu Biology Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ringpu Biology Recent Developments/Updates
2.5 Yebio
2.5.1 Yebio Details
2.5.2 Yebio Major Business
2.5.3 Yebio Newcastle Disease Vaccine Product and Services
2.5.4 Yebio Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yebio Recent Developments/Updates
2.6 Harbin Veterinary Research Institute
2.6.1 Harbin Veterinary Research Institute Details
2.6.2 Harbin Veterinary Research Institute Major Business
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
2.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
2.7.4 Merck Animal Health Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Merck Animal Health Recent Developments/Updates
2.8 DHN
2.8.1 DHN Details
2.8.2 DHN Major Business
2.8.3 DHN Newcastle Disease Vaccine Product and Services
2.8.4 DHN Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DHN Recent Developments/Updates
2.9 Zoetis
2.9.1 Zoetis Details
2.9.2 Zoetis Major Business
2.9.3 Zoetis Newcastle Disease Vaccine Product and Services
2.9.4 Zoetis Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Zoetis Recent Developments/Updates
2.10 Elanco
2.10.1 Elanco Details
2.10.2 Elanco Major Business
2.10.3 Elanco Newcastle Disease Vaccine Product and Services
2.10.4 Elanco Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Elanco Recent Developments/Updates
2.11 FATRO
2.11.1 FATRO Details
2.11.2 FATRO Major Business
2.11.3 FATRO Newcastle Disease Vaccine Product and Services
2.11.4 FATRO Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 FATRO Recent Developments/Updates
2.12 CAVAC
2.12.1 CAVAC Details
2.12.2 CAVAC Major Business
2.12.3 CAVAC Newcastle Disease Vaccine Product and Services
2.12.4 CAVAC Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 CAVAC Recent Developments/Updates
2.13 Vaksindo
2.13.1 Vaksindo Details
2.13.2 Vaksindo Major Business
2.13.3 Vaksindo Newcastle Disease Vaccine Product and Services
2.13.4 Vaksindo Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Vaksindo Recent Developments/Updates
2.14 Virbac
2.14.1 Virbac Details
2.14.2 Virbac Major Business
2.14.3 Virbac Newcastle Disease Vaccine Product and Services
2.14.4 Virbac Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Virbac Recent Developments/Updates
2.15 Hester Biosciences
2.15.1 Hester Biosciences Details
2.15.2 Hester Biosciences Major Business
2.15.3 Hester Biosciences Newcastle Disease Vaccine Product and Services
2.15.4 Hester Biosciences Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Hester Biosciences Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEWCASTLE DISEASE VACCINE BY MANUFACTURER
3.1 Global Newcastle Disease Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Newcastle Disease Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2025
3.5 Newcastle Disease Vaccine Market: Overall Company Footprint Analysis
3.5.1 Newcastle Disease Vaccine Market: Region Footprint
3.5.2 Newcastle Disease Vaccine Market: Company Product Type Footprint
3.5.3 Newcastle Disease Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Newcastle Disease Vaccine Market Size by Region
4.1.1 Global Newcastle Disease Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Newcastle Disease Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Newcastle Disease Vaccine Average Price by Region (2021-2032)
4.2 North America Newcastle Disease Vaccine Consumption Value (2021-2032)
4.3 Europe Newcastle Disease Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Newcastle Disease Vaccine Consumption Value (2021-2032)
4.5 South America Newcastle Disease Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Newcastle Disease Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Newcastle Disease Vaccine Consumption Value by Type (2021-2032)
5.3 Global Newcastle Disease Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Newcastle Disease Vaccine Consumption Value by Application (2021-2032)
6.3 Global Newcastle Disease Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Newcastle Disease Vaccine Market Size by Country
7.3.1 North America Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Newcastle Disease Vaccine Market Size by Country
8.3.1 Europe Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Newcastle Disease Vaccine Market Size by Region
9.3.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Newcastle Disease Vaccine Market Size by Country
10.3.1 South America Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Country
11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Newcastle Disease Vaccine Market Drivers
12.2 Newcastle Disease Vaccine Market Restraints
12.3 Newcastle Disease Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Newcastle Disease Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Newcastle Disease Vaccine
13.3 Newcastle Disease Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Newcastle Disease Vaccine Typical Distributors
14.3 Newcastle Disease Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live Vaccines
1.3.3 Killed Vaccines
1.4 Market Analysis by Administration
1.4.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Administration: 2021 Versus 2025 Versus 2032
1.4.2 Spray Method
1.4.3 Drinking Water
1.4.4 Injection Method
1.5 Market Analysis by End User
1.5.1 Overview: Global Newcastle Disease Vaccine Consumption Value by End User: 2021 Versus 2025 Versus 2032
1.5.2 Large Farms
1.5.3 Small Farms
1.5.4 Government Use
1.6 Market Analysis by Application
1.6.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Chicken
1.6.3 Duck & Goose
1.6.4 Other
1.7 Global Newcastle Disease Vaccine Market Size & Forecast
1.7.1 Global Newcastle Disease Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Newcastle Disease Vaccine Sales Quantity (2021-2032)
1.7.3 Global Newcastle Disease Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
2.1.4 Boehringer Ingelheim Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 CEVA
2.2.1 CEVA Details
2.2.2 CEVA Major Business
2.2.3 CEVA Newcastle Disease Vaccine Product and Services
2.2.4 CEVA Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CEVA Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Newcastle Disease Vaccine Product and Services
2.3.4 CAHIC Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CAHIC Recent Developments/Updates
2.4 Ringpu Biology
2.4.1 Ringpu Biology Details
2.4.2 Ringpu Biology Major Business
2.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
2.4.4 Ringpu Biology Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ringpu Biology Recent Developments/Updates
2.5 Yebio
2.5.1 Yebio Details
2.5.2 Yebio Major Business
2.5.3 Yebio Newcastle Disease Vaccine Product and Services
2.5.4 Yebio Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yebio Recent Developments/Updates
2.6 Harbin Veterinary Research Institute
2.6.1 Harbin Veterinary Research Institute Details
2.6.2 Harbin Veterinary Research Institute Major Business
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
2.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
2.7.4 Merck Animal Health Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Merck Animal Health Recent Developments/Updates
2.8 DHN
2.8.1 DHN Details
2.8.2 DHN Major Business
2.8.3 DHN Newcastle Disease Vaccine Product and Services
2.8.4 DHN Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DHN Recent Developments/Updates
2.9 Zoetis
2.9.1 Zoetis Details
2.9.2 Zoetis Major Business
2.9.3 Zoetis Newcastle Disease Vaccine Product and Services
2.9.4 Zoetis Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Zoetis Recent Developments/Updates
2.10 Elanco
2.10.1 Elanco Details
2.10.2 Elanco Major Business
2.10.3 Elanco Newcastle Disease Vaccine Product and Services
2.10.4 Elanco Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Elanco Recent Developments/Updates
2.11 FATRO
2.11.1 FATRO Details
2.11.2 FATRO Major Business
2.11.3 FATRO Newcastle Disease Vaccine Product and Services
2.11.4 FATRO Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 FATRO Recent Developments/Updates
2.12 CAVAC
2.12.1 CAVAC Details
2.12.2 CAVAC Major Business
2.12.3 CAVAC Newcastle Disease Vaccine Product and Services
2.12.4 CAVAC Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 CAVAC Recent Developments/Updates
2.13 Vaksindo
2.13.1 Vaksindo Details
2.13.2 Vaksindo Major Business
2.13.3 Vaksindo Newcastle Disease Vaccine Product and Services
2.13.4 Vaksindo Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Vaksindo Recent Developments/Updates
2.14 Virbac
2.14.1 Virbac Details
2.14.2 Virbac Major Business
2.14.3 Virbac Newcastle Disease Vaccine Product and Services
2.14.4 Virbac Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Virbac Recent Developments/Updates
2.15 Hester Biosciences
2.15.1 Hester Biosciences Details
2.15.2 Hester Biosciences Major Business
2.15.3 Hester Biosciences Newcastle Disease Vaccine Product and Services
2.15.4 Hester Biosciences Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Hester Biosciences Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEWCASTLE DISEASE VACCINE BY MANUFACTURER
3.1 Global Newcastle Disease Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Newcastle Disease Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2025
3.5 Newcastle Disease Vaccine Market: Overall Company Footprint Analysis
3.5.1 Newcastle Disease Vaccine Market: Region Footprint
3.5.2 Newcastle Disease Vaccine Market: Company Product Type Footprint
3.5.3 Newcastle Disease Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Newcastle Disease Vaccine Market Size by Region
4.1.1 Global Newcastle Disease Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Newcastle Disease Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Newcastle Disease Vaccine Average Price by Region (2021-2032)
4.2 North America Newcastle Disease Vaccine Consumption Value (2021-2032)
4.3 Europe Newcastle Disease Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Newcastle Disease Vaccine Consumption Value (2021-2032)
4.5 South America Newcastle Disease Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Newcastle Disease Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Newcastle Disease Vaccine Consumption Value by Type (2021-2032)
5.3 Global Newcastle Disease Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Newcastle Disease Vaccine Consumption Value by Application (2021-2032)
6.3 Global Newcastle Disease Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Newcastle Disease Vaccine Market Size by Country
7.3.1 North America Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Newcastle Disease Vaccine Market Size by Country
8.3.1 Europe Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Newcastle Disease Vaccine Market Size by Region
9.3.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Newcastle Disease Vaccine Market Size by Country
10.3.1 South America Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Country
11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Newcastle Disease Vaccine Market Drivers
12.2 Newcastle Disease Vaccine Market Restraints
12.3 Newcastle Disease Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Newcastle Disease Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Newcastle Disease Vaccine
13.3 Newcastle Disease Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Newcastle Disease Vaccine Typical Distributors
14.3 Newcastle Disease Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Newcastle Disease Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Newcastle Disease Vaccine Consumption Value by Administration, (USD Million), 2021 & 2025 & 2032
Table 3. Global Newcastle Disease Vaccine Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 4. Global Newcastle Disease Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 6. Boehringer Ingelheim Major Business
Table 7. Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
Table 8. Boehringer Ingelheim Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Boehringer Ingelheim Recent Developments/Updates
Table 10. CEVA Basic Information, Manufacturing Base and Competitors
Table 11. CEVA Major Business
Table 12. CEVA Newcastle Disease Vaccine Product and Services
Table 13. CEVA Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CEVA Recent Developments/Updates
Table 15. CAHIC Basic Information, Manufacturing Base and Competitors
Table 16. CAHIC Major Business
Table 17. CAHIC Newcastle Disease Vaccine Product and Services
Table 18. CAHIC Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. CAHIC Recent Developments/Updates
Table 20. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 21. Ringpu Biology Major Business
Table 22. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 23. Ringpu Biology Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Ringpu Biology Recent Developments/Updates
Table 25. Yebio Basic Information, Manufacturing Base and Competitors
Table 26. Yebio Major Business
Table 27. Yebio Newcastle Disease Vaccine Product and Services
Table 28. Yebio Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Yebio Recent Developments/Updates
Table 30. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 31. Harbin Veterinary Research Institute Major Business
Table 32. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 33. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Harbin Veterinary Research Institute Recent Developments/Updates
Table 35. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Merck Animal Health Major Business
Table 37. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 38. Merck Animal Health Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Merck Animal Health Recent Developments/Updates
Table 40. DHN Basic Information, Manufacturing Base and Competitors
Table 41. DHN Major Business
Table 42. DHN Newcastle Disease Vaccine Product and Services
Table 43. DHN Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. DHN Recent Developments/Updates
Table 45. Zoetis Basic Information, Manufacturing Base and Competitors
Table 46. Zoetis Major Business
Table 47. Zoetis Newcastle Disease Vaccine Product and Services
Table 48. Zoetis Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Zoetis Recent Developments/Updates
Table 50. Elanco Basic Information, Manufacturing Base and Competitors
Table 51. Elanco Major Business
Table 52. Elanco Newcastle Disease Vaccine Product and Services
Table 53. Elanco Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Elanco Recent Developments/Updates
Table 55. FATRO Basic Information, Manufacturing Base and Competitors
Table 56. FATRO Major Business
Table 57. FATRO Newcastle Disease Vaccine Product and Services
Table 58. FATRO Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. FATRO Recent Developments/Updates
Table 60. CAVAC Basic Information, Manufacturing Base and Competitors
Table 61. CAVAC Major Business
Table 62. CAVAC Newcastle Disease Vaccine Product and Services
Table 63. CAVAC Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. CAVAC Recent Developments/Updates
Table 65. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 66. Vaksindo Major Business
Table 67. Vaksindo Newcastle Disease Vaccine Product and Services
Table 68. Vaksindo Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Vaksindo Recent Developments/Updates
Table 70. Virbac Basic Information, Manufacturing Base and Competitors
Table 71. Virbac Major Business
Table 72. Virbac Newcastle Disease Vaccine Product and Services
Table 73. Virbac Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Virbac Recent Developments/Updates
Table 75. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 76. Hester Biosciences Major Business
Table 77. Hester Biosciences Newcastle Disease Vaccine Product and Services
Table 78. Hester Biosciences Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Hester Biosciences Recent Developments/Updates
Table 80. Global Newcastle Disease Vaccine Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 81. Global Newcastle Disease Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 82. Global Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 83. Market Position of Manufacturers in Newcastle Disease Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 84. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 85. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 86. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 87. Newcastle Disease Vaccine New Market Entrants and Barriers to Market Entry
Table 88. Newcastle Disease Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Newcastle Disease Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 90. Global Newcastle Disease Vaccine Sales Quantity by Region (2021-2026) & (M Doses)
Table 91. Global Newcastle Disease Vaccine Sales Quantity by Region (2027-2032) & (M Doses)
Table 92. Global Newcastle Disease Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 93. Global Newcastle Disease Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 94. Global Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 95. Global Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 96. Global Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 97. Global Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 98. Global Newcastle Disease Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 99. Global Newcastle Disease Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 100. Global Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 101. Global Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 102. Global Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 103. Global Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 104. Global Newcastle Disease Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Global Newcastle Disease Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Global Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 107. Global Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 108. North America Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 109. North America Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 110. North America Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 111. North America Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 112. North America Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 113. North America Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 114. North America Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 117. Europe Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 118. Europe Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 119. Europe Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 120. Europe Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 121. Europe Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 122. Europe Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 123. Europe Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 125. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 126. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 127. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 128. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2021-2026) & (M Doses)
Table 129. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2027-2032) & (M Doses)
Table 130. Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 131. Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 132. South America Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 133. South America Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 134. South America Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 135. South America Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 136. South America Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 137. South America Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 138. South America Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 139. South America Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 141. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 142. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 143. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 144. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 145. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 146. Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 147. Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 148. Newcastle Disease Vaccine Raw Material
Table 149. Key Manufacturers of Newcastle Disease Vaccine Raw Materials
Table 150. Newcastle Disease Vaccine Typical Distributors
Table 151. Newcastle Disease Vaccine Typical Customers
Table 1. Global Newcastle Disease Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Newcastle Disease Vaccine Consumption Value by Administration, (USD Million), 2021 & 2025 & 2032
Table 3. Global Newcastle Disease Vaccine Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 4. Global Newcastle Disease Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 6. Boehringer Ingelheim Major Business
Table 7. Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
Table 8. Boehringer Ingelheim Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Boehringer Ingelheim Recent Developments/Updates
Table 10. CEVA Basic Information, Manufacturing Base and Competitors
Table 11. CEVA Major Business
Table 12. CEVA Newcastle Disease Vaccine Product and Services
Table 13. CEVA Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CEVA Recent Developments/Updates
Table 15. CAHIC Basic Information, Manufacturing Base and Competitors
Table 16. CAHIC Major Business
Table 17. CAHIC Newcastle Disease Vaccine Product and Services
Table 18. CAHIC Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. CAHIC Recent Developments/Updates
Table 20. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 21. Ringpu Biology Major Business
Table 22. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 23. Ringpu Biology Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Ringpu Biology Recent Developments/Updates
Table 25. Yebio Basic Information, Manufacturing Base and Competitors
Table 26. Yebio Major Business
Table 27. Yebio Newcastle Disease Vaccine Product and Services
Table 28. Yebio Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Yebio Recent Developments/Updates
Table 30. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 31. Harbin Veterinary Research Institute Major Business
Table 32. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 33. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Harbin Veterinary Research Institute Recent Developments/Updates
Table 35. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Merck Animal Health Major Business
Table 37. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 38. Merck Animal Health Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Merck Animal Health Recent Developments/Updates
Table 40. DHN Basic Information, Manufacturing Base and Competitors
Table 41. DHN Major Business
Table 42. DHN Newcastle Disease Vaccine Product and Services
Table 43. DHN Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. DHN Recent Developments/Updates
Table 45. Zoetis Basic Information, Manufacturing Base and Competitors
Table 46. Zoetis Major Business
Table 47. Zoetis Newcastle Disease Vaccine Product and Services
Table 48. Zoetis Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Zoetis Recent Developments/Updates
Table 50. Elanco Basic Information, Manufacturing Base and Competitors
Table 51. Elanco Major Business
Table 52. Elanco Newcastle Disease Vaccine Product and Services
Table 53. Elanco Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Elanco Recent Developments/Updates
Table 55. FATRO Basic Information, Manufacturing Base and Competitors
Table 56. FATRO Major Business
Table 57. FATRO Newcastle Disease Vaccine Product and Services
Table 58. FATRO Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. FATRO Recent Developments/Updates
Table 60. CAVAC Basic Information, Manufacturing Base and Competitors
Table 61. CAVAC Major Business
Table 62. CAVAC Newcastle Disease Vaccine Product and Services
Table 63. CAVAC Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. CAVAC Recent Developments/Updates
Table 65. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 66. Vaksindo Major Business
Table 67. Vaksindo Newcastle Disease Vaccine Product and Services
Table 68. Vaksindo Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Vaksindo Recent Developments/Updates
Table 70. Virbac Basic Information, Manufacturing Base and Competitors
Table 71. Virbac Major Business
Table 72. Virbac Newcastle Disease Vaccine Product and Services
Table 73. Virbac Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Virbac Recent Developments/Updates
Table 75. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 76. Hester Biosciences Major Business
Table 77. Hester Biosciences Newcastle Disease Vaccine Product and Services
Table 78. Hester Biosciences Newcastle Disease Vaccine Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Hester Biosciences Recent Developments/Updates
Table 80. Global Newcastle Disease Vaccine Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 81. Global Newcastle Disease Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 82. Global Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 83. Market Position of Manufacturers in Newcastle Disease Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 84. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 85. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 86. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 87. Newcastle Disease Vaccine New Market Entrants and Barriers to Market Entry
Table 88. Newcastle Disease Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Newcastle Disease Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 90. Global Newcastle Disease Vaccine Sales Quantity by Region (2021-2026) & (M Doses)
Table 91. Global Newcastle Disease Vaccine Sales Quantity by Region (2027-2032) & (M Doses)
Table 92. Global Newcastle Disease Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 93. Global Newcastle Disease Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 94. Global Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 95. Global Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 96. Global Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 97. Global Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 98. Global Newcastle Disease Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 99. Global Newcastle Disease Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 100. Global Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 101. Global Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 102. Global Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 103. Global Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 104. Global Newcastle Disease Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Global Newcastle Disease Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Global Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 107. Global Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 108. North America Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 109. North America Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 110. North America Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 111. North America Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 112. North America Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 113. North America Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 114. North America Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 117. Europe Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 118. Europe Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 119. Europe Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 120. Europe Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 121. Europe Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 122. Europe Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 123. Europe Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 125. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 126. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 127. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 128. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2021-2026) & (M Doses)
Table 129. Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2027-2032) & (M Doses)
Table 130. Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 131. Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 132. South America Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 133. South America Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 134. South America Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 135. South America Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 136. South America Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 137. South America Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 138. South America Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 139. South America Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2021-2026) & (M Doses)
Table 141. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2027-2032) & (M Doses)
Table 142. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2021-2026) & (M Doses)
Table 143. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2027-2032) & (M Doses)
Table 144. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2021-2026) & (M Doses)
Table 145. Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2027-2032) & (M Doses)
Table 146. Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 147. Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 148. Newcastle Disease Vaccine Raw Material
Table 149. Key Manufacturers of Newcastle Disease Vaccine Raw Materials
Table 150. Newcastle Disease Vaccine Typical Distributors
Table 151. Newcastle Disease Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. Global Newcastle Disease Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Newcastle Disease Vaccine Revenue Market Share by Type in 2025
Figure 4. Live Vaccines Examples
Figure 5. Killed Vaccines Examples
Figure 6. Global Newcastle Disease Vaccine Revenue by Administration, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Newcastle Disease Vaccine Revenue Market Share by Administration in 2025
Figure 8. Spray Method Examples
Figure 9. Drinking Water Examples
Figure 10. Injection Method Examples
Figure 11. Global Newcastle Disease Vaccine Revenue by End User, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Newcastle Disease Vaccine Revenue Market Share by End User in 2025
Figure 13. Large Farms Examples
Figure 14. Small Farms Examples
Figure 15. Government Use Examples
Figure 16. Global Newcastle Disease Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 18. Chicken Examples
Figure 19. Duck & Goose Examples
Figure 20. Other Examples
Figure 21. Global Newcastle Disease Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Newcastle Disease Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Newcastle Disease Vaccine Sales Quantity (2021-2032) & (M Doses)
Figure 24. Global Newcastle Disease Vaccine Price (2021-2032) & (USD/K Doses)
Figure 25. Global Newcastle Disease Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Newcastle Disease Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Newcastle Disease Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Newcastle Disease Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 40. Global Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032)
Figure 42. Global Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 43. North America Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. France Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Newcastle Disease Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 63. China Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. India Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 83. Newcastle Disease Vaccine Market Drivers
Figure 84. Newcastle Disease Vaccine Market Restraints
Figure 85. Newcastle Disease Vaccine Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine in 2025
Figure 88. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 89. Newcastle Disease Vaccine Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. Global Newcastle Disease Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Newcastle Disease Vaccine Revenue Market Share by Type in 2025
Figure 4. Live Vaccines Examples
Figure 5. Killed Vaccines Examples
Figure 6. Global Newcastle Disease Vaccine Revenue by Administration, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Newcastle Disease Vaccine Revenue Market Share by Administration in 2025
Figure 8. Spray Method Examples
Figure 9. Drinking Water Examples
Figure 10. Injection Method Examples
Figure 11. Global Newcastle Disease Vaccine Revenue by End User, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Newcastle Disease Vaccine Revenue Market Share by End User in 2025
Figure 13. Large Farms Examples
Figure 14. Small Farms Examples
Figure 15. Government Use Examples
Figure 16. Global Newcastle Disease Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 18. Chicken Examples
Figure 19. Duck & Goose Examples
Figure 20. Other Examples
Figure 21. Global Newcastle Disease Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Newcastle Disease Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Newcastle Disease Vaccine Sales Quantity (2021-2032) & (M Doses)
Figure 24. Global Newcastle Disease Vaccine Price (2021-2032) & (USD/K Doses)
Figure 25. Global Newcastle Disease Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Newcastle Disease Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Newcastle Disease Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Newcastle Disease Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 40. Global Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032)
Figure 42. Global Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 43. North America Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. France Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Newcastle Disease Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Newcastle Disease Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 63. China Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. India Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Newcastle Disease Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Newcastle Disease Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Newcastle Disease Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 83. Newcastle Disease Vaccine Market Drivers
Figure 84. Newcastle Disease Vaccine Market Restraints
Figure 85. Newcastle Disease Vaccine Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine in 2025
Figure 88. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 89. Newcastle Disease Vaccine Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
